Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ELI LILLY AND CO

  • FDA Approval
  • July 31, 2023, 20:27 UTC
  • 41
  • 0 comments

FDA approve TIRZEPATIDE

Comment Full text

HARM REDUCTION THERAPEUTICS

  • FDA Approval
  • July 28, 2023, 18:41 UTC
  • 39
  • 0 comments

FDA approve NALOXONE HYDROCHLORIDE

Comment Full text

IPR

  • FDA Approval
  • July 28, 2023, 11:44 UTC
  • 34
  • 0 comments

FDA approve ROSUVASTATIN CALCIUM

Comment Full text

BAYER HEALTHCARE LLC

  • FDA Approval
  • July 28, 2023, 11:44 UTC
  • 29
  • 0 comments

FDA approve POLYETHYLENE GLYCOL 3350

Comment Full text

BIOVITRUM AB

  • FDA Approval
  • July 28, 2023, 11:44 UTC
  • 31
  • 0 comments

FDA approve PALIFERMIN

Comment Full text

PHARMACIA

  • FDA Approval
  • July 28, 2023, 11:44 UTC
  • 33
  • 0 comments

FDA approve PEGVISOMANT

Comment Full text

HQ SPECLT PHARMA

  • FDA Approval
  • July 27, 2023, 20:16 UTC
  • 29
  • 0 comments

FDA approve MEROPENEM

Comment Full text

STEMLINE THERAPEUTICS INC

  • FDA Approval
  • July 27, 2023, 11:54 UTC
  • 30
  • 0 comments

FDA approve TAGRAXOFUSP-ERZS

Comment Full text

SEAGEN

  • FDA Approval
  • July 27, 2023, 11:54 UTC
  • 33
  • 0 comments

FDA approve TISOTUMAB VEDOTIN-TFTV

Comment Full text

STERISCIENCE

  • FDA Approval
  • July 27, 2023, 08:12 UTC
  • 31
  • 0 comments

FDA approve CARBOPROST TROMETHAMINE

Comment Full text
  • Previous
  • 752
  • 753
  • 754
  • 755
  • 756
  • Next

Search

News categories

  • Technical Exchange News(12054)
  • Event(5289)
  • SEC News(250725)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150063)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin